Multicenter phase I trial of a DNA vaccine encoding the androgen receptor ligand binding domain (pTVG-AR, MVI-118) in patients with metastatic prostate cancer-MedSci.cn

Multicenter phase I trial of a DNA vaccine encoding the androgen receptor ligand binding domain (pTVG-AR, MVI-118) in patients with metastatic prostate cancer

McNeel, DG; Saraiya, B; Schweizer, M; Eickhoff, J; Wargowski, E; Lesniewski, R; Olson, B; Kyriakopoulos, C

ANNALS OF ONCOLOGY, 2019; 30 (): 343

科室
- - 订阅+
  - 更多科室
工具
服务